Literature DB >> 15361354

Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver.

Takashi Kudo1, Emiko Nakayama, Sawako Suzuki, Masashi Akiyama, Shigenobu Shibata.   

Abstract

Myocardial infarction frequently occurs in the morning, a phenomenon in part resulting from the downregulation of fibrinolytic activity. Plasminogen activator inhibitor-1 (PAI-1) is a key factor behind fibrinolytic activity, and its gene expression is controlled under the circadian clock gene in the mouse heart and liver. Hypercholesterolemia has been associated with impaired fibrinolysis due to enhanced PAI-1 activity, which has also been implicated in atherosclerosis. The aim of this study was to decipher whether the Pai-1 gene is still expressed daily with hypercholesterolemia. Hypercholesterolemia (1% cholesterol diet) did not significantly affect the daily expression of clock genes (Per2 and Bmal1) and clock-controlled genes (Dbp and E4bp4) in the liver (P > 0.05); however, daily expression of the Pai-1 gene and Pai-1 promoter regulating factor genes such as Nr4a1 was significantly upregulated (P < 0.01). Daily restricted feeding for 4 h during the day reset the gene expression of Per2, Pai-1, Nr4a1, and Tnf-alpha. Lesion of the suprachiasmatic nucleus, the location of the main clock system, led to loss of Per2 and Pai-1 daily expression profiles. In the present experiments, we demonstrated that hypercholesterolemia enhanced daily expression of the Pai-1, Tnf-alpha, and Nr4a1 genes in the mouse liver without affecting clock and clock-controlled genes. Therefore, the risk or high frequency of acute atherothrombotic events in the morning still seems to be a factor that may be augmented under conditions of hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361354     DOI: 10.1152/ajpendo.00095.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle.

Authors:  Frank A J L Scheer; Steven A Shea
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

2.  Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.

Authors:  Jose A Diaz; Nicole E Ballard-Lipka; Diana M Farris; Angela E Hawley; Shirley K Wrobleski; Daniel D Myers; Peter K Henke; Daniel A Lawrence; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2011-11-25       Impact factor: 4.268

3.  Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.

Authors:  K A Patterson; X Zhang; S K Wrobleski; A E Hawley; D A Lawrence; T W Wakefield; D D Myers; J A Diaz
Journal:  Thromb Res       Date:  2012-12-29       Impact factor: 3.944

Review 4.  Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes.

Authors:  Chenyang Zhang; Bin Zhang; Xuelian Zhang; Guibo Sun; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2020-11-27       Impact factor: 5.810

5.  Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.

Authors:  Li-Fu Li; Chung-Chi Huang; Horng-Chyuan Lin; Ying-Huang Tsai; Deborah A Quinn; Shuen-Kuei Liao
Journal:  Crit Care       Date:  2009-07-06       Impact factor: 9.097

6.  Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice.

Authors:  W John Sheward; Elizabeth S Maywood; Karen L French; Jacqueline M Horn; Michael H Hastings; Jonathan R Seckl; Megan C Holmes; Anthony J Harmar
Journal:  J Neurosci       Date:  2007-04-18       Impact factor: 6.167

7.  Plasma Membrane Profiling Reveals Upregulation of ABCA1 by Infected Macrophages Leading to Restriction of Mycobacterial Growth.

Authors:  Jing Long; Robindra Basu Roy; Yanjia J Zhang; Robin Antrobus; Yuxian Du; Duncan L Smith; Michael P Weekes; Babak Javid
Journal:  Front Microbiol       Date:  2016-07-12       Impact factor: 5.640

Review 8.  The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.

Authors:  Lei Zhang; Qun Wang; Wen Liu; Fangyan Liu; Ailing Ji; Yanzhang Li
Journal:  J Diabetes Res       Date:  2018-06-14       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.